BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16442827)

  • 1. [Soft tissue sarcomas: update on molecular data].
    Bui Nguyen Binh M; Collin F; Coindre JM
    Cancer Radiother; 2006; 10(1-2):15-21. PubMed ID: 16442827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of chromosomal abnormalities in soft tissue sarcomas: which sarcomas? Which abnormalities? How? Why?].
    Genevay M; Gengler C; Guillou L
    Bull Cancer; 2007 Sep; 94(9):781-92. PubMed ID: 17878098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of genetic testing in soft tissue sarcoma.
    Antonescu CR
    Histopathology; 2006 Jan; 48(1):13-21. PubMed ID: 16359533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Soft tissue sarcomas: clinical application of molecular biology].
    Chetaille B; Laibe S; Choukeir N; Bertucci F
    Rev Prat; 2013 Mar; 63(3):309-13. PubMed ID: 23687749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of specific genetic abnormalities by fluorescence in situ hybridization in soft tissue tumors.
    Miura Y; Keira Y; Ogino J; Nakanishi K; Noguchi H; Inoue T; Hasegawa T
    Pathol Int; 2012 Jan; 62(1):16-27. PubMed ID: 22192800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [What is the value of recent molecular biology knowledge for surgical oncologic therapy of soft tissue sarcoma?].
    Willeke F
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():393-8. PubMed ID: 9931648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soft tissue tumours: the impact of cytogenetics and molecular genetics.
    Fletcher CD
    Verh Dtsch Ges Pathol; 1997; 81():318-26. PubMed ID: 9474886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular biology of soft-tissue sarcomas].
    Coindre JM
    Bull Cancer; 2010 Nov; 97(11):1337-45. PubMed ID: 21084242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical relevance of molecular genetics in soft tissue sarcomas.
    Ordóñez JL; Osuna D; García-Domínguez DJ; Amaral AT; Otero-Motta AP; Mackintosh C; Sevillano MV; Barbado MV; Hernández T; de Alava E
    Adv Anat Pathol; 2010 May; 17(3):162-81. PubMed ID: 20418671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-grade abdominopelvic sarcoma with myofibroblastic features (low-grade myofibroblastic sarcoma): clinicopathological, immunohistochemical, molecular genetic and ultrastructural study of two cases with literature review.
    Agaimy A; Wünsch PH; Schroeder J; Gaumann A; Dietmaier W; Hartmann A; Hofstaedter F; Mentzel T
    J Clin Pathol; 2008 Mar; 61(3):301-6. PubMed ID: 17513510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens.
    Matsuyama A; Hisaoka M; Shimajiri S; Hayashi T; Imamura T; Ishida T; Fukunaga M; Fukuhara T; Minato H; Nakajima T; Yonezawa S; Kuroda M; Yamasaki F; Toyoshima S; Hashimoto H
    Am J Surg Pathol; 2006 Sep; 30(9):1077-84. PubMed ID: 16931951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular diagnosis of routine sarcomas].
    Coindre JM
    Ann Pathol; 2008 Nov; 28 Spec No 1(1):S64-5. PubMed ID: 18984305
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
    Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
    BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.
    Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO
    Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms.
    Downs-Kelly E; Goldblum JR; Patel RM; Weiss SW; Folpe AL; Mertens F; Hartke M; Tubbs RR; Skacel M
    Am J Surg Pathol; 2008 Jan; 32(1):8-13. PubMed ID: 18162764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathology and potential therapeutic targets in soft-tissue sarcoma.
    Todd R; Lunec J
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):939-48. PubMed ID: 18533803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of cytogenetics to the management of poorly differentiated sarcomas.
    Bridge JA
    Ultrastruct Pathol; 2008; 32(2):63-71. PubMed ID: 18446669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in the genomics of soft tissue sarcomas.
    Conley AP; Trent J; Zhang W
    Curr Opin Oncol; 2008 Jul; 20(4):395-9. PubMed ID: 18525334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetics and molecular biology of soft tissue tumors.
    Fletcher JA
    Monogr Pathol; 1996; 38():37-64. PubMed ID: 8744274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undifferentiated sarcoma: does it exist? A clinicopathologic study of 7 pediatric cases and review of literature.
    Alaggio R; Bisogno G; Rosato A; Ninfo V; Coffin CM
    Hum Pathol; 2009 Nov; 40(11):1600-10. PubMed ID: 19647855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.